PD-1 inhibitor in combination with fruquintinib therapy for initial unresectable colorectal cancer: A case report

doi:10.12998/wjcc.v10.i14.4669

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4107)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

211

WORD

HTML

2043

Figures (1-5)

300

Tables (1-1)

282

Sum=2931

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

344

Download

832

Sum=1176

May 16, 2022 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. May 16, 2022; 10(14): 4669-4675
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4669

Full Size Figure Download Figure

Figure 5 Abdominal computed tomography examination (2021-11): Postoperative review showed no evidence of recurrence.

Citation: Zhang HQ, Huang CZ, Wu JY, Wang ZL, Shao Y, Fu Z. PD-1 inhibitor in combination with fruquintinib therapy for initial unresectable colorectal cancer: A case report. World J Clin Cases 2022; 10(14): 4669-4675
URL: https://www.wjgnet.com/2307-8960/full/v10/i14/4669.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i14.4669